Re Rns1 Dec 2022 20:02
· On 31 October 2022 the Company announced that it had agreed with its lenders of a debt position due 31 October 2022, to make an immediate repayment of £150,000 with the residual balance of £627,600 being deferred to 31 March 2023. The Company has further agreed a refinancing fee of £77,760 to be paid by 23 December 2022 in new ordinary shares of the Company to be priced at the lowest VWAP of the Company's shares as traded between 31 October 2022 and 20 December 2022. The Lenders will have the right to convert any outstanding balances into equity at the Strike Price between 20 December 2022 and 31 March 2023. The outstanding balances will accrue a monthly coupon of 1%. The Company further agreed to a series of potential accelerated repayment scenarios in the event that asset sales for cash or new equity placings were completed before the balance of the loan amounts fell due. The Company also agreed that before 20 December 2022 it would either pay a fee of £475,000 in aggregate to the Lenders or extend 112,500,000 of existing warrants currently allowing purchase of new ordinary shares at a price of £0.004 until 20 February 2024, to an extended term where they remain exercisable until 31 March 2025, with a related resettability clause associated with these warrants to also be extended until 31 December 2023.